FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Alembic Pharmaceuticals Tobramycin Opthalmic Solution Recall

Tobramycin Opthalmic Solution USP, 0

ALEMBIC PHARMACEUTICALS, INC. · Bedminster, NJ

Risk level
Class III
Reported by FDA
Aug 23, 2023
Recall ID
D-1086-2023
Check your lot numberHow we source this data

Summary

Alembic Pharmaceuticals recalled Tobramycin Opthalmic Solution starting Jul 27, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1086-2023 on Aug 23, 2023. Reason: Failed Impurities/Degradation Specifications. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05

Lot numbers, UPCs & expiration codes

Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1086-2023
Classification
Class III
Status
Ongoing
Recall initiated
Jul 27, 2023
FDA report date
Aug 23, 2023
Quantity
82,400 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
ALEMBIC PHARMACEUTICALS, INC.

Original FDA data

Every field from FDA enforcement report D-1086-2023, exactly as published.

Show all FDA fields
City
Bedminster
State
NJ
Status
Ongoing
Country
United States
Event ID
92811
Address
550 Hills Dr Ste 104b
Code information
Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024
Postal code
07921-1537
Report date
Aug 23, 2023
Product type
Drugs
Recall number
D-1086-2023
Classification
Class III
Recalling firm
ALEMBIC PHARMACEUTICALS, INC.
Product quantity
82,400 bottles
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 27, 2023
Initial firm notification
Letter
Center classification date
Aug 17, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1086-2023, published Aug 23, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls